We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.09%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$50.8B
AUM Growth
-$294M
(-0.58%)
Cap. Flow
-$328M
Cap. Flow
% of AUM
-0.65%
Top 10 Holdings %
Top 10 Hldgs %
22.21%
Holding
1,137
New
127
Increased
273
Reduced
442
Closed
122
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$255M |
| 2 |
Textron
TXT
|
+$206M |
| 3 |
AstraZeneca
AZN
|
+$164M |
| 4 |
ExxonMobil
XOM
|
+$124M |
| 5 |
Moderna
MRNA
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$962M |
| 2 |
WORK
Slack Technologies, Inc.
WORK
|
+$204M |
| 3 |
Devon Energy
DVN
|
+$201M |
| 4 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$170M |
| 5 |
Carrier Global
CARR
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.3% |
| 2 | Healthcare | 15.98% |
| 3 | Financials | 14.49% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Communication Services | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Campbell Soup
CPB
$6.73B
| $8.89M | 0.02% |
+212,746
| New | +$9.24M |
|
727
Federal Realty Investment Trust
FRT
$10.2B
| $8.84M | 0.02% |
74,900
-1,100
| -1% | -$130K |
|
728
Newell Brands
NWL
$2.56B
| $8.83M | 0.02% |
398,700
-5,800
| -1% | -$148K |
|
729
GH Research
GHRS
$2.1B
| $8.82M | 0.02% |
400,000
-65,000
| -14% | -$1.32M |
|
730
Arrowhead Research
ARWR
$12.1B
| $8.74M | 0.02% |
140,000
-10,000
| -7% | -$647K |
|
|
SSAA
731
DELISTED
Science Strategic Acquisition Corp. Alpha Class A Common Stock
SSAA
| $8.74M | 0.02% |
900,000
| – | – |
|
732
DaVita
DVA
$11.5B
| $8.72M | 0.02% |
75,000
-7,400
| -9% | -$927K |
|
|
ACRO
733
DELISTED
Acropolis Infrastructure Acquisition Corp
ACRO
| $8.71M | 0.02% |
+900,000
| New | +$8.75M |
|
734
Valaris
VAL
$5.35B
| $8.68M | 0.02% |
248,864
-428,436
| -63% | -$12.3M |
|
735
Janux Therapeutics
JANX
$982M
| $8.65M | 0.02% |
400,000
-50,000
| -11% | -$1.44M |
|
736
Consolidated Edison
ED
$40.2B
| $8.61M | 0.02% |
+118,646
| New | +$8.86M |
|
737
Whirlpool
WHR
$2.8B
| $8.6M | 0.02% |
42,166
-26,000
| -38% | -$5.7M |
|
|
SOGU
738
DELISTED
AXS Short De-SPAC Daily ETF
SOGU
| $8.58M | 0.02% |
303,000
-175,000
| -37% | -$4.79M |
|
739
EPAM Systems
EPAM
$4.86B
| $8.56M | 0.02% |
+15,000
| New | +$8.83M |
|
740
Marqeta
MQ
$1.74B
| $8.52M | 0.02% |
96,250
-42,642
| -31% | -$4.56M |
|
741
Organon & Co
OGN
$3.56B
| $8.52M | 0.02% |
259,680
+99,150
| +62% | +$3.17M |
|
|
FSRD
742
DELISTED
Fast Radius, Inc. Class A Common Stock
FSRD
| $8.4M | 0.02% |
850,000
-1,149,400
| -57% | -$11.3M |
|
|
AQNU
743
DELISTED
Algonquin Power & Utilities Corp Units
AQNU
| $8.37M | 0.02% |
172,877
-627,123
| -78% | -$31.8M |
|
744
Toast
TOST
$20.1B
| $8.37M | 0.02% |
+167,500
| New | +$9.16M |
|
745
Franklin Resources
BEN
$17.3B
| $8.36M | 0.02% |
281,200
-4,300
| -2% | -$134K |
|
|
BHVN
746
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $8.34M | 0.02% |
+60,000
| New | +$7.49M |
|
|
FSSI
747
DELISTED
Fortistar Sustainable Solutions Corp. Class A Common Stock
FSSI
| $8.3M | 0.02% |
850,000
| – | – |
|
748
Playtika
PLTK
$1.25B
| $8.29M | 0.02% |
300,000
| – | – |
|
749
SES AI
SES
$187M
| $8.29M | 0.02% |
837,058
-962,942
| -53% | -$9.57M |
|
|
SEE
750
DELISTED
Sealed Air
SEE
| $8.27M | 0.02% |
150,875
-2,300
| -2% | -$134K |
|
Similar funds
Adage Capital Partners's Q3 2021 Portfolio in Review
As of Q3 2021, Adage Capital Partners held 1,137 positions worth $50.8B, down 0.58% from $51.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Adage Capital Partners's Q3 2021 filing shows 127 new, 273 increased, 442 reduced and 122 closed positions. Its largest new stake was Pfizer: 5,759,101 shares worth $248M. The largest sale was Alexion Pharmaceuticals, an estimated $962M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q3 2021 buy was Pfizer: 5,759,101 shares worth $248M.
- Adage Capital Partners added most to Textron in Q3 2021, an estimated $206M increase.
- Adage Capital Partners's biggest Q3 2021 reduction was Devon Energy, cutting an estimated $201M.
- Adage Capital Partners fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $962M.
- Adage Capital Partners's ten largest holdings make up 22% of its $50.8B portfolio in Q3 2021.
- Adage Capital Partners opened 127 new positions and closed 122 in Q3 2021.
- Adage Capital Partners's portfolio value fell 0.58% quarter-over-quarter to $50.8B.
Based on Adage Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.